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Decreasing Clostirdium Difﬁcile Infection Rates through
Enhanced Practice Guidelines
Azure Grossman, Deanna Schafer. Blood and Marrow
Transplant, Froedtert Hospital & The Medical College of
Wisconsin, Milwaukee, WI
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Clostridium difﬁcileeassociated disease (CDAD) is associated
with increased length of stay, cost of care, and signiﬁcant
morbidity and mortality. The adult blood and marrow trans-
plant population is at high risk for infection due to multiple
factors. These factors include: prolonged neutropenia, anti-
microbial use, conditioning regimens, immunosuppression,
and the suppression of gastric acid. Starting in May 2013, our
unit saw a sharp increase in our hospital acquired CDAD. Our
goal was to decrease the number of hospital acquired CDAD
infections on our unit by implementing new practice
guidelines.
Methods, Intervention, & Analysis: In June 2013 our unit
educator and CNS along with our coordinating council devel-
oped new practice guidelines to control the spread of Clos-
tridium difﬁcile. These guidelineswere developed to be used in
addition to our hospital’s comprehensive infection control
policy. The new guidelines included universal gloving for all
patient contact, restrictingour unit kitchen to staff only, double
bagging isolation linens and garbage, bleaching the linen carts
after use and bleachwiping high touch-point areas in isolation
rooms three times a day. We also put signs outside of each C.
difﬁcile room instructing visitors and staff to wash with soap
and water. We began bleach wiping high touch-point areas
throughout the unit on a daily basis. These guidelines were
emailed to staff and also reviewed in monthly staff meetings.
Findings & Interpretation: In the Spring/Summer of 2013,
our unit had the highest rates of CDAD in the hospital. Our
peak rate was 14.2 per 1000 patient days. Through our new
guidelines, we were able to decrease our rate to 2.8 per 1000
patient days.
Discussion & Implications: C. difﬁcile infection prevention is
an ongoing process. This summer, our unit saw a small spike
in infection rates, and with re-education of last year’s
guidelines via email and staff meetings, we’ve seen our rates
decrease again.
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Happy Birthday.Again: Educating BMT Nurses and
Patients about Infusion of Stem Cells
Karen Lyse Harden 1, Alex Lorenz 2, Shellie Conn 2. 1 School of
Nursing, University of Michigan, Ann Arbor, MI; 2 University of
Michigan Health Systems, Ann Arbor, MI
Topic Signiﬁcance & Study Purpose/Background/Rationale:
The purpose of this project was to establish a program of
competency for bone marrow transplant nurses regarding
administration of Stem Cells on Day 0 of transplant hospital-
ization and to provide education to the patients and families
about what to expect during transplant.
In this institution the responsibility of infusion of stem
cells historically belonged to the midlevel providers and
physicians. The literature does not specify who should
administer the stem cells but the FACT (Foundation for the
Accreditation of Cellular Therapy) standards state that “There
shall be a policy addressing safe administration of cellular
therapy products.” This project highlights education of nurses
and nursing management during stem cell infusion and pa-
tient/caregiver education for monitoring of adverse reactionsduring and after infusion of stem cells. We realized the
importance of training nurses correctly, making them feel
comfortable with the procedure and providing patients with
the safest stem cell administration possible.
Methods, Intervention, & Analysis: Development of a sys-
tematic education program was important to make sure
nurses learned the knowledge behind the procedure of stem
cell infusion. This included reading and understanding pro-
cesses from BMT Standard Operating Procedures, preparing
premeds, emergency equipment and IV supplies, verifying
stem cell products with blood bank staff, performing stem
cell infusion, monitoring vital signs and watching for signs of
a reaction, and documenting the stem cell infusion.
Findings & Interpretation: We accomplished the develop-
ment of a Stem Cell Infusion competency and training pro-
gram, and 27 nurses have been fully trained to administer
stem cells to BMT patients. Nine nurses are currently in
training to administer stem cells. We developed resource
materials to support new nurses in the learning the process,
developed RN checklists for stem cell infusion procedure and
developed patient education sheets in the UM Clearinghouse
that simply explain the procedure of stem cell infusion for
patients and families to learn.
Discussion & Implications: Patients feel comfortable when
their nurse is involved in the Day 0 stem cell infusion. Patient
feedback shows that nurses with conﬁrmed competency,
knowledge and skill, and the relationship with their patients
and families have proven to be the ideal people to administer
stem cells to their patients.575
Early Intervention with HSCT Patients to Improve Access
to and Knowledge of Palliative Care
Karen Lyse Harden 1, Patricia Lyndale 2, Josette Schembri 3.
1 School of Nursing, University of Michigan, Ann Arbor, MI;
2 Spiritual Care, University of Michigan Health Systems, Ann
Arbor, MI; 3University of Michigan Health Systems, Ann Arbor, MI
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Our purpose was to formally initiate palliative care services
early (prior to admission) for Hematopoietic Stem Cell
Transplant (HSCT) patients thereby improving access and
knowledge for patients and their families throughout all
hospitalizations. Physicians, nurses and patients/families
struggle regarding issues related to palliative care. Statistics
indicate that some HSCT patients have only a 15-45% survival
rate at ﬁve years; therefore, could use the extra support. A
practice gap existed between our practice for HSCT patients
regarding palliative care and the recommended evidenced-
based guidelines from the National Comprehensive Cancer
Network (NCCN). The characteristics from NCCN that qualify
patients for palliative care are indicative of many patients
who are hospitalized for transplant.
Methods, Intervention, & Analysis: The palliative care team
facilitated two meetings for the patients. Meeting #1 was
outpatient prior to admission with a focus on information.
Meeting #2 was inpatient approximately eight days post
stem cell transplant with a focus on individualizing the plan
of care for the patient. Interventions provided by palliative
care included: Advanced Care Navigation e “preparedness
planning” and consistent supportive communication. Dis-
cussion topics included: patient values and hopes, what is
meaningful to them, collaboration about goals of care, and
anticipatory guidance. A patient questionnaire was
completed by the patient after the completion of meeting #2.
An exit interview with the palliative care team at the
Figure.
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Findings & Interpretation: Data collection occurred over a
period of 17 months, with a total of 25 patients to complete
the study. 92% of the patients felt they had the information
needed to access palliative care. 84% of the patients reported
an increase in knowledge about palliative care.
Discussion & Implications: Data indicates that there was an
increased knowledge and understanding of palliative care,
and an improved ability to access palliative care. Although the
beneﬁt of early palliative care is clear in the literature, anec-
dotal results reveal it is difﬁcult to know when the patients
will be emotionally and intellectually most ready to learn.
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Providing a Safety Net for Bone Marrow Transplant (BMT)
Survivors: Nurses and Telephone Triage
Anne Chafee, AmyHeissenbuttel, Rose Rivett, MihkaiWickline.
Seattle Cancer Care Alliance, Seattle, WA
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Long term follow-up (LTFU) of patients transplanted in an
NCI-designated Cancer Center is a key ingredient for
improving ongoing quality of life and overall survival. The
telephone triage consult service at the Seattle Cancer Care
Alliance answers the BMT-related questions of post-trans-
plant survivors and their local providers after discharge from
the Center. LTFU Telephone Triage is staffedMonday-Friday by
registered nurses (RNs) who manage approximately 80 calls
per week from a population of over 5,600 transplant survi-
vors. This successful service demands expertise in the recog-
nition of signs and symptoms of late acute and chronic Graft
versus Host Disease (GVHD), infection, and other complica-
tions of transplantation. This department is an essential link in
providing optimal post-transplant care in the survivor’s local
community.
Objectives: Symptoms of transplant complications are
caught early and appropriately treated to promote quality
long term survival.
Collaboration between telephone triage team, survivors,
family, and local providers improves quality of post-trans-
plant care.
Meaningful research can be done to improve LTFU patient
outcomes.
Methods, Intervention, & Analysis: Essential elements for a
successful LTFU RN Telephone Triage service are: establish-
ing and maintaining an organized service; teaching survi-
vors how to access the service during their departure
education; ensuring an accessible service; stafﬁng with a
dedicated, multidisciplinary team including support staff,
transplant-experienced RNs, attending physicians with
post-transplant expertise, and other specialty consultants;
holding thrice weekly rounds for reviewing cases and
formulating clinical recommendations; developing tools
used to streamline patient monitoring such as the LTFU ﬂow
sheet, LTFU charts, RN Sign-outs, Center-speciﬁc LTFU clin-
ical practice guidelines; cultivating positive working re-
lationships with local medical providers; and utilizing
sophisticated electronic systems.
Findings & Interpretation: Continued access to LTFU ex-
perts is critical in assisting survivors and their local practi-
tioners in managing care. Telephone triage serves as a safety
net for these survivors with complex and unique needs after
transplant.
Discussion & Implications: Patient satisfaction for the LTFU
service is high and meaningful research continues to
improve outcomes as we identify new areas for interventionfrom this population. The ultimate metric of success of the
telephone triage team work is seen in the exceptional 1-yr
and 5-yr survival outcomes at the Seattle Cancer Care Alli-
ance.577
Weight Based Plerixafor Dosing Reduces Side Effects in
Stem Cell Mobilization
Jennifer Bourke 1, Koen van Besien 2, Sapna Parmar 3,
Janel Joaquin 1, Cindy Ippoliti 4. 1 Bone Marrow Transplant,
NewYork-Presbyterian Hospital Weill Cornell Medical Center,
New York, NY; 2Weill Cornell Medical College, New York, NY;
3 Pharmacy, NewYork-Presbyterian Hospital/Weill Cornell
Medical Center, New York, NY; 4 Pharmacy, NYP/Cornell, NY, NY
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Autologous stem cell mobilization is enhanced by use of
plerixafor in combination with G-CSF, particularly in other-
wise poor mobilizers. At New York Presbyterian Weill/Cornell
we determined CD34 count on day four of G-CSF and added
plerixafor for those whose CD34 count was <20 cells/mcL.
Plerixafor dosing was based on both weight and kidney
function (EGFR>60ml/min/m2: 24mg; EGFR<60 andweight
>50 Kg: 24 mg; EGFR <60 and weight < 50 Kg: 12 mg). This
algorithm was implemented in early 2013 and was quite
effective in stem cell mobilization. The required number of
apheresis per patient was much reduced (Cushing et al, sub-
mitted). However, out of 55 patients, 12 experienced a variety
of side effects including diarrhea, abdominal pain, nausea,
vomiting, sweating, insomnia, paresthesias, jaw tightness,
blurred vision, difﬁculty walking, and in one case hallucina-
tions. These side-effects occurred within hours of adminis-
tration of plerixafor and in most patients resolved within 24
hours.
Methods, Intervention, & Analysis: There was a clear as-
sociation between body weight and occurrence of this
syndrome. The median weight of those with side-effects
was 60, compared to a median weight of 80 for those
without side-effects. (p<0.001 -ﬁgure). The dosing algo-
rithmwas adjusted as follows: EGFR>60 and weight of >75
Kg: 24 mg, 51-75 Kg: 18 mg and </¼ 50 Kg:12 mg. Further
dose reductions are implemented for pts with reduced
EGFR. EGFR is <50 and >75 kg: 16 mg, 51-75 Kg: 12 mg,
and</¼ 50 Kg: 8 mg.
